Clinical Trial Update: Abuse Potential of Buprenorphine/Naloxone [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the abuse potential of buprenorphine/naloxone in individuals with opioid use disorders. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 2 | Status: TERMINATED